DSSECA

DSSECA appears to be an early-stage medtech company or commercialization project associated with the University of Maryland focused on oxidative stress detection. Public descriptions characterize it as a platform device intended to identify biomarker signatures of oxidative stress from blood and apply signal processing to chemical analysis for hospital use. The company has been referenced in pediatric medical device innovation programs, including the MedTech Innovator pediatric accelerator, suggesting a translational device-development effort rather than a therapeutics developer. Available public information does not show an approved product, clinical-stage therapeutic pipeline, major financing, or public-market listing. Based on the limited evidence available, DSSECA is best categorized as a private, very early-stage healthcare diagnostics/device company.